Invicon Diagnostic Concepts

Executive Summary

Invicon Diagnostic Concepts is a Berlin-based German diagnostics company founded in 2005, specializing in third-party quality control (QC) materials for clinical laboratories. Its product portfolio spans clinical chemistry, immunoassays, protein diagnostics, drugs/toxicology (TDM), and trace elements, covering serum, urine, and whole blood matrices. As an independent QC provider, Invicon plays a critical role in helping laboratories meet accreditation standards and ensure reliable patient results. The company operates in a stable niche with recurring revenue from consumables, but faces competition from larger QC manufacturers. Growth opportunities lie in expanding its product range, entering new geographic markets (e.g., the US), and leveraging regulatory trends favoring independent QC. With a lean operation and established reputation in Europe, Invicon is positioned for steady, low-risk growth.

Upcoming Catalysts (preview)

• Q4 2026FDA clearance for US market entry of key QC products40% success
• Q2 2026Launch of new QC panel for emerging biomarkers (e.g., cardiac or oncology)60% success
• TBDPartnership or distribution agreement with a major lab diagnostics distributor50% success